Please use this identifier to cite or link to this item: http://hdl.handle.net/10773/40042
Full metadata record
DC FieldValueLanguage
dc.contributor.authorFelgueiras, Julianapt_PT
dc.contributor.authorLobo, Joãopt_PT
dc.contributor.authorCamilo, Vâniapt_PT
dc.contributor.authorCarneiro, Isapt_PT
dc.contributor.authorMatos, Bárbarapt_PT
dc.contributor.authorHenrique, Ruipt_PT
dc.contributor.authorJerónimo, Carmenpt_PT
dc.contributor.authorFardilha, Margaridapt_PT
dc.date.accessioned2024-01-10T11:31:39Z-
dc.date.available2024-01-10T11:31:39Z-
dc.date.issued2022-09-15-
dc.identifier.issn0014-4827pt_PT
dc.identifier.urihttp://hdl.handle.net/10773/40042-
dc.description.abstractThe Ser/Thr-protein phosphatase PP1 (PP1) is a positive regulator of the androgen receptor (AR), which suggests major roles for PP1 in prostate carcinogenesis. However, studies dedicated to the characterization of PP1 in PCa are currently scarce. Here we analyzed the expression and localization of the PP1 catalytic (PP1c) isoforms in formalin-fixed, paraffin-embedded prostate tissue samples, as well as in PCa cell lines. We also analyzed well-characterized PCa cohorts to determine their transcript levels, identify genetic alterations, and assess promoter methylation of PP1c-coding genes. We found that PP-1A was upregulated and relocalized towards the nucleus in PCa and that PPP1CA was frequently amplified in PCa, particularly in advanced stages. PP-1B was downregulated in PCa but upregulated in a subset of tumors with AR amplification. PP-1G transcript levels were found to be associated with Gleason score. PP1c-coding genes were rarely mutated in PCa and were not prone to regulation by promoter methylation. Protein phosphorylation, on the other hand, might be an important regulatory mechanism of PP1c isoforms' activity. Altogether, our results suggest differential expression, localization, and regulation of PP1c isoforms in PCa and support the need for investigating isoform-specific roles in prostate carcinogenesis in future studies.pt_PT
dc.language.isoengpt_PT
dc.publisherElsevierpt_PT
dc.relationinfo:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDB%2F04501%2F2020/PTpt_PT
dc.relationPOCI-01-0145-FEDER-022122pt_PT
dc.relationSFRH/BD/102981/2014pt_PT
dc.relationinfo:eu-repo/grantAgreement/FCT//SFRH%2FBD%2F132751%2F2017/PTpt_PT
dc.relationPTDC/MECONC/29030/2017pt_PT
dc.rightsopenAccesspt_PT
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/pt_PT
dc.subjectIsoformspt_PT
dc.subjectMethylationpt_PT
dc.subjectMutationspt_PT
dc.subjectPhosphatasept_PT
dc.subjectPhosphorylationpt_PT
dc.titlePP1 catalytic isoforms are differentially expressed and regulated in human prostate cancerpt_PT
dc.typearticlept_PT
dc.description.versionpublishedpt_PT
dc.peerreviewedyespt_PT
degois.publication.issue2pt_PT
degois.publication.titleExperimental Cell Researchpt_PT
degois.publication.volume418pt_PT
dc.identifier.doi10.1016/j.yexcr.2022.113282pt_PT
dc.identifier.essn1090-2422pt_PT
dc.identifier.articlenumber113282pt_PT
Appears in Collections:IBIMED - Artigos
DCM - Artigos

Files in This Item:
File Description SizeFormat 
1-s2.0-S0014482722002750-main.pdf5.78 MBAdobe PDFView/Open


FacebookTwitterLinkedIn
Formato BibTex MendeleyEndnote Degois 

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.